120 related articles for article (PubMed ID: 6547562)
1. Neuropeptide Y (NPY) depresses the secretion of 3H-noradrenaline and the contractile response evoked by field stimulation, in rat vas deferens.
Lundberg JM; Stjarne L
Acta Physiol Scand; 1984 Mar; 120(3):477-9. PubMed ID: 6547562
[No Abstract] [Full Text] [Related]
2. Effects of neuropeptide Y (NPY) on mechanical activity and neurotransmission in the heart, vas deferens and urinary bladder of the guinea-pig.
Lundberg JM; Hua XY; Franco-Cereceda A
Acta Physiol Scand; 1984 Aug; 121(4):325-32. PubMed ID: 6091417
[TBL] [Abstract][Full Text] [Related]
3. Reserpine-induced potentiation of the inhibitory action of neuropeptide Y on the rat vas deferens neurotransmission.
Huidobro-Toro JP
Neurosci Lett; 1985 Sep; 59(3):247-52. PubMed ID: 2997668
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms underlying pre- and postjunctional effects of neuropeptide Y in sympathetic vascular control.
Pernow J; Saria A; Lundberg JM
Acta Physiol Scand; 1986 Feb; 126(2):239-49. PubMed ID: 3010640
[TBL] [Abstract][Full Text] [Related]
5. The effects of pancreatic polypeptides and neuropeptide Y on the rat vas deferens.
Ohhashi T; Jacobowitz DM
Peptides; 1983; 4(3):381-6. PubMed ID: 6688871
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y--a cotransmitter with noradrenaline and adenosine 5'-triphosphate in the sympathetic nerves of the mouse vas deferens? A biochemical, physiological and electropharmacological study.
Stjärne L; Lundberg JM; Astrand P
Neuroscience; 1986 May; 18(1):151-66. PubMed ID: 3755512
[TBL] [Abstract][Full Text] [Related]
7. Effects of neuropeptide Y (NPY) at the sympathetic neuroeffector junction. Can pre- and postjunctional receptors be distinguished?
Wahlestedt C; Håkanson R
Med Biol; 1986; 64(2-3):85-8. PubMed ID: 3018392
[TBL] [Abstract][Full Text] [Related]
8. Two novel related peptides, neuropeptide Y (NPY) and peptide YY (PYY) inhibit the contraction of the electrically stimulated mouse vas deferens.
Allen JM; Adrian TE; Tatemoto K; Polak JM; Hughes J; Bloom SR
Neuropeptides; 1982 Dec; 3(2):71-7. PubMed ID: 6186938
[No Abstract] [Full Text] [Related]
9. Neuropeptide Y inhibits 3[H]noradrenaline release in the rat vas deferens independently of cAMP levels.
Bitran M; Torres G; Tapia W; Huidobro-Toro JP
Neurochem Int; 1996 Mar; 28(3):309-17. PubMed ID: 8813249
[TBL] [Abstract][Full Text] [Related]
10. Comparative structural requirements of brain neuropeptide Y binding sites and vas deferens neuropeptide Y receptors.
Martel JC; Fournier A; St-Pierre S; Dumont Y; Forest M; Quirion R
Mol Pharmacol; 1990 Oct; 38(4):494-502. PubMed ID: 2172766
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y (NPY): an endogenous modulator of non-adrenergic transmission in rat vas deferens?
Huidobro-Toro JP; Rohde G; Tatemoto K
Eur J Pharmacol; 1985 Feb; 109(2):317-8. PubMed ID: 2987004
[No Abstract] [Full Text] [Related]
12. Age-dependent modulation of neuropeptide Y on adrenergic transmission of guinea pig vas deferens.
Chernaeva L; Yankova M
Gen Pharmacol; 1991; 22(4):611-6. PubMed ID: 1657685
[TBL] [Abstract][Full Text] [Related]
13. Responsiveness of the rat vas deferens to catecholamines and electrical stimulation during an infection with Trypanosoma brucei.
Adeboye OO; Oriowo MA
Afr J Med Med Sci; 1984; 13(3-4):135-8. PubMed ID: 6099973
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y (NPY) reduces field stimulation-evoked release of noradrenaline and enhances force of contraction in the rat portal vein.
Dahlöf C; Dahlöf P; Tatemoto K; Lundberg JM
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):327-30. PubMed ID: 3838576
[TBL] [Abstract][Full Text] [Related]
15. Coexistence and cooperation between neuropeptide Y and norepinephrine in nerve fibers of guinea pig vas deferens and seminal vesicle.
Stjernquist M; Owman C; Sjöberg NO; Sundler F
Biol Reprod; 1987 Feb; 36(1):149-55. PubMed ID: 3552066
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y (NPY)-like immunoreactivity in peripheral noradrenergic neurons and effects of NPY on sympathetic function.
Lundberg JM; Terenius L; Hökfelt T; Martling CR; Tatemoto K; Mutt V; Polak J; Bloom S; Goldstein M
Acta Physiol Scand; 1982 Dec; 116(4):477-80. PubMed ID: 6763452
[No Abstract] [Full Text] [Related]
17. A comparison of inhibitory effects of neuropeptide Y on rat urinary bladder, urethra, and vas deferens.
Zoubek J; Somogyi GT; De Groat WC
Am J Physiol; 1993 Sep; 265(3 Pt 2):R537-43. PubMed ID: 8214143
[TBL] [Abstract][Full Text] [Related]
18. Evidence for the co-storage and co-release of neuropeptide Y and noradrenaline from large dense cored vesicles in sympathetic nerves of the bovine vas deferens.
De Potter WP; Dillen L; Annaert W; Tombeur K; Berghmans R; Coen EP
Synapse; 1988; 2(2):157-62. PubMed ID: 3420537
[TBL] [Abstract][Full Text] [Related]
19. Effects of prazosin and phentolamine on responses to field stimulation and to noradrenaline in vas deferens and anococcygeus muscle of the rat.
Doggrell SA; Paton DM
Arch Int Pharmacodyn Ther; 1978 Jun; 233(2):209-20. PubMed ID: 686912
[TBL] [Abstract][Full Text] [Related]
20. Postjunctional supersensitivity of the smooth muscle of the rat vas deferens induced by calmodulin-antagonizing drugs applied locally to the hypogastric plexus.
Goto K
J Pharmacol Exp Ther; 1983 Jan; 224(1):231-8. PubMed ID: 6294279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
